NFKB1 and bipolar disorder: For example, miR-9 exerts a negative feedback on NFκB and is dysregulated in neural progenitor cells of schizophrenia patients [43]; miR-132 inhibits inflammation signaling (via acetylcholine, STAT3, and NFKB) and is dysregulated in schizophrenia [44]; miR-146 inhibits inflammatory responses and is downregulated in monocytes of postpartum psychosis patients [45]; and miR-149 inhibits LPS-induced inflammation (via STAT3, NFκB, TNF, IL-6) and is a candidate biomarker of psychiatric disease including bipolar disorders [46].